1,298
Views
50
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Components of the COPD Assessment Test (CAT) associated with a diagnosis of COPD in a random population sample

, , , , , , , & show all
Pages 175-183 | Published online: 12 Mar 2012

References

  • Yawn B, Mannino D, Littlejohn T, Ruoff G, Emmett A, Raphiou I, Crater G. Prevalence of COPD among symptomatic patients in a primary care setting. Curr Med Res Opin 2009; 25(11):2671–2677.
  • Mannino DM, Gagnon RC, Petty TL, Lydick E. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2000; 160(11):1683–1689.
  • Bednarek M, Maciejewski J, Wozniak M, Kuca P, Zielinski J. Prevalence, severity and underdiagnosis of COPD in the primary care setting. Thorax 2008; 63(5):402–407.
  • Mapel DW, Robinson SB, Dastani HB, Shah H, Phillips AL, Lydick E. The direct medical costs of undiagnosed chronic obstructive pulmonary disease. Value Health 2008; 11(4):628–636.
  • U.S. Preventive Services Task Force. Screening for chronic obstructive pulmonary disease using spirometry: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008; 148(7):529–534.
  • O'Donnell DE, Aaron S, Bourbeau J, Hernandez P, Marciniuk DD, Balter M, Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease –2007 update. Can Respir J 2007; 14(Suppl B):5B–32B.
  • Rabe KF, Hurd S, Anzueto A, Barnes PL, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176(6):532–555.
  • Celli BR, MacNee W; on behalf of the ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23(6):932–946.
  • Freeman D, Nordyke RJ, Isonaka S, Nonikov DV, Maroni JM, Price D, Halbert RJ. Questions for COPD diagnostic screening in a primary care setting. Respir Med 2005; 99(10):1311–1318.
  • Yawn BP, Mapel DW, Mannino DM, Martinez FJ, Donohue JF, Hanania NA, Kosinski M, Rendas-Baum R, Mintz M, Samuels S, Dalal AA. Development of the Lung Function Questionnaire (LFQ) to identify airflow obstruction. Int J COPD 2010; 5:1–10.
  • Hanania NA, Mannino DM, Yawn BP, Mapel DW, Martinez FJ, Donohue JF, Kosinski M, Rendas-Baum R, Mintz M, Samuels S, Jhingran P, Dalal AA. Predicting risk of airflow obstruction in primary care: Validation of the lung function questionnaire (LFQ). Respir Med 2010; 104(8):1160–1170.
  • Calverley PMA, Nordyke RJ, Halbert RJ, Isonaka S, Nonikov D. Development of a population-based screening questionnaire for COPD. COPD 2005; 2(2):225–232.
  • Martinez FJ, Raczek AE, Seifer FD, Conoscenti CS, Curtice TG, D'Eletto T, Cote C, Hawkins C, Phillips AL. Development and initial validation of a self-scored COPD Population Screener Questionnaire (COPD-PS). COPD 2008; 5(2):85–95.
  • van Schayck CP, Loozen JM, Wagena E, Akkermans RP, Wesseling GJ. Detecting patients at a high risk of developing chronic obstructive pulmonary disease in general practice: cross sectional case finding study. Br Med J 2002; 324(7350):1370.
  • Price DB, Tinkelman DG, Halbert RJ, Nordyke RJ, Isonaka S, Nonikov D, Juniper EF, Freeman D, Hausen T, Levy ML, Østrem A, van der Molen T, van Schayck CP. Symptom-based questionnaire for identifying COPD in smokers. Respir 2006; 73(3):285–295.
  • Kotz D, Nelemans P, van Schayck CP, Wesseling GJ. External validation of a COPD diagnostic questionnaire. Eur Respir J 2008; 31(2):298–303.
  • Swanney MP, Ruppel G, Enright PL, Pedersen OF, Crapo RO, Miller MR, Jensen RL, Falaschetti E, Schouten JP, Hankinson JL, Stocks J, Quanjer PH. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax 2008; 63(12):1046–1051.
  • Jones P, Harding G, Wiklund I, Berry P, Kline Leidy N. Improving the process and outcome of care in COPD: development of a standardised assessment tool. Prim Care Respir J 2009; 18(3):208–215.
  • Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J 2009; 34(3):648–654.
  • Jones PW, Brusselle G, Dal Negro RW, Ferrer M, Kardos P, Levy ML, Perez T, Soler Cataluña JJ, van der Molen T, Adamek L, Banik N. Properties of the COPD assessment test in a cross-sectional European study. Eur Respir J 2011; 38(1):29–35.
  • Dodd JW, Hogg L, Nolan J, Jefford H, Grant A, Lord VM, Falzon C, Garrod R, Lee C, Polkey MI, Jones PW, Man WDC, Hopkinson NS. The COPD Assessment Test (CAT): response to pulmonary rehabilitation. A multicentre, prospective study. Thorax 2011; 66(5):425–429.
  • Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999; 159(1):179–187.
  • American Thoracic Society (ATS); Task Group on Screening for Respiratory Disease in Occupational Settings. Surveillance for respiratory hazards in the occupational setting. Am Rev Respir Dis 1982; 126:952–956.
  • Miller MR, Hankinson J, Brusasco V, et al.; on behalf of the American Thoracic Society/European Respiratory Society (ATS/ERS) Task Force. Standardisation of spirometry. Eur Respir J 2005; 26:319–338.
  • Hosmer DW, Lemeshow S. Applied Logistic Regression. 2nd ed. New York: Wiley; 2000.
  • Altman DG, Royston P. What do we mean by validating a prognostic model? Stat Med 2000; 19(4):453–473.
  • Buist AS, McBurnie MA, Vollmer WM, et al.; on behalf of the BOLD Collaborative Research Group. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007; 370(9589):741–750.
  • Ofir D, Laveneziana P, Webb KA, Lam YM, O'Donnell DE. Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 177(6):622–629.
  • O'Donnell DE, Laveneziana P, Ora J, Webb KA, Lam Y-M, Ofir D. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD. Thorax 2009; 64(3):216–223.
  • Guenette JA, Jensen D, Webb KA, Ofir D, Raghavan N, O'Donnell DE. Sex differences in exertional dyspnea in patients with mild COPD: Physiological mechanisms. Respir Physiol Neurobiol 2011; 177(3):218–227.
  • Deesomchok A, Webb KA, Forkert L, Lam YM, Ofir D, Jensen D, O'Donnell DE. Lung hyperinflation and its reversibility in patients with airway obstruction of varying severity. COPD 2010; 7(6):428–437.
  • Stavem K, Sandvik I, Eriksson J. Can global lung initiative for chronic obstructive lung disease stage 0 provide prognostic information on long term mortality in men? Chest 2006; 130(2):318–325.
  • Montes de Oca M, Tálamo C, Halbert RJ, Perez-Padilla R, Lopez MV, Muiño A, Jardim JR, Valdivia G, Pertuzé J, Moreno D, Menezes AM; PLATINO Team. Health status perception and airflow obstruction in five Latin American cities: the PLATINO study. Respir Med 2009; 103(9):1376–1382.
  • Pitta F, Troosters T, Spruit MA, Decramer M, Gosselink R. Activity monitoring for assessment of physical activities in daily life in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil 2005; 86(10):1979–1985.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.